(Q44222287)

English

Derivatization of F2-isoprostanes with 1-pyrenyldiazomethane and their subsequent determination by fluorescence high-performance liquid chromatography

scientific article published in December 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 December 2017

Derivatization of F2-isoprostanes with 1-pyrenyldiazomethane and their subsequent determination by fluorescence high-performance liquid chromatography (English)

1 reference

Europe PubMed Central

1 December 2017

0 references

high-performance liquid chromatography

1 reference

based on heuristic

inferred from title

Valerian E. Kagan

3

object named as

Valerian E Kagan

1 reference

Europe PubMed Central

1 December 2017

author name string

Vladimir B Ritov

1

1 reference

Europe PubMed Central

1 December 2017

David E Kelley

2

1 reference

Europe PubMed Central

1 December 2017

language of work or name

0 references

publication date

1 December 2002

1 reference

Europe PubMed Central

1 December 2017

Analytical Biochemistry

1 reference

Europe PubMed Central

1 December 2017

311

1 reference

Europe PubMed Central

1 December 2017

1

1 reference

Europe PubMed Central

1 December 2017

10-18

1 reference

Europe PubMed Central

1 December 2017

The isoprostanes: their quantification as an index of oxidant stress status in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

The isoprostanes: a perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

Nomenclature of isoprostanes: a proposal.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

A nomenclature system for the isoprostanes.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

Identification of two major F2 isoprostanes, 8,12-iso- and 5-epi-8, 12-iso-isoprostane F2alpha-VI, in human urine

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

Analysis of F2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

Determination of isoprostaglandin F2alpha type III in human urine by gas chromatography-electronic impact mass spectrometry. Comparison with enzyme immunoassay.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

Evidence that the F2-isoprostane, 8-epi-prostaglandin F2 alpha, is formed in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

Use of derivatization to improve the chromatographic properties and detection selectivity of physiologically important carboxylic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

Femtomole analysis of prostaglandin pharmaceuticals

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

1-Pyrenyldiazomethane as a fluorescent labeling reagent for liquid chromatographic determination of carboxylic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

Increased formation of distinct F2 isoprostanes in hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

Total synthesis of 17,17,18,18-d4-iPF2alpha-VI and quantification of iPF2alpha-VI in human urine by gas chromatography/mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

Localization of distinct F2-isoprostanes in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

Identification and relative quantitation of F2-isoprostane regioisomers formed in vivo in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

Characterization of signal transduction events stimulated by 8-epi-prostaglandin(PG)F2 alpha in rat aortic rings

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

Measurement of urinary 8-Epi-prostaglandin F2alpha, a novel index of lipid peroxidation in vivo, by immunoaffinity extraction/gas chromatography-mass spectrometry. Basal levels in smokers and nonsmokers

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

Specific analysis in plasma and urine of 2,3-dinor-5, 6-dihydro-isoprostane F(2alpha)-III, a metabolite of isoprostane F(2alpha)-III and an oxidation product of gamma-linolenic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

IPF2alpha-I: an index of lipid peroxidation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urine

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

Mass spectrometric analysis of four regioisomers of F2-isoprostanes formed by free radical oxidation of arachidonic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

Streamlined F2-isoprostane analysis in plasma and urine with high-performance liquid chromatography and gas chromatography/mass spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

Oxidative stress following traumatic brain injury in rats: quantitation of biomarkers and detection of free radical intermediates

1 reference

https://api.crossref.org/works/10.1016%2FS0003-2697%2802%2900392-5

7 January 2021

Identifiers

10.1016/S0003-2697(02)00392-5

1 reference

Europe PubMed Central

1 December 2017

1 reference

Europe PubMed Central

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44222287&oldid=2108695718"